CrownBio - Translating Biology Into Medicine
  • Drug Design
    • Fragment-Based Lead Generation
    • Computational chemistry
    • Structure biology
    • Medicinal chemistry
    • Quantitative biology
    • DMPK & Bioanalysis
    • Formulation
  • ABOUT US
  • THE BUZZ
  • Updates
  • Events
  • News
  • Job Posting
  • FAQ
  • CONTACT
  • Cancer Biology
  • Metabolic Disease
  • Drug Design
  • Biotherapeutics

Quantitative biology

Tuesday, 21 June 2011 08:08 frontend
E-mail Print PDF

The mission for Quantitative Biology is to provide medium throughput and quantitative evaluation of compounds efficacy in various biological systems. Such data will provide guidance for the reiterative effort in compound optimization.

Our capabilities in Quantitative Biology include:

  • Purified enzyme and cell-based assays
  • Medium throughput fragment compound screening
  • Potency and specificity analysis for compound SAR modification
  • In vivo target inhibition (IVTI) analysis
  • Mechanism of action analysis

* Mean-Ratio (MR) =1.01, Ratio Limits (RLs) =(0.94-1.08)

* Minimum Significant Ratio (MSR) =1.372, Limits of Agreement (LsA) =(0.73-1.38)

                                 Sample validation data for enzymatic assay

 

DMPK & Bioanalysis

 

Last Updated on Monday, 31 October 2011 04:50  

Copyright © 1999-2011 Crown Bio Science Inc. All Rights Reserved. - TEL:+1.855.827.6968 | Login